Digital Health: The Impact of Standardising DHI Terminology

By Staff Writer

April 13, 2024

Introduction

The digital health sector is experiencing a rapid transformation, fuelled by advancements in technologies such as artificial intelligence (AI), digital therapeutics and remote monitoring. Despite the promise of Digital Health Interventions (DHIs), the industry struggles with unclear nomenclature. Which, in turn, hinders the process of evidence synthesis and the delivery of healthcare. The Professional Society for Health Economics and Outcomes Research (ISPOR)’s special interest group underscores the necessity of a unified framework for patient-facing DHIs, aiming to enhance their impact on health economic and outcomes research.

The Challenge of Ambiguous Terminology

DHIs offer unprecedented opportunities for patient-centred care, yet their diverse nature poses significant challenges. A plethora of terms and definitions lead to confusion, some overlapping, complicating the assessment of these interventions. The lack of standardisation not only hinders the comparability of studies but also the adoption of DHIs in clinical practice. Guidelines cover systematic evidence evaluation of DHI investigations. The Evidence in Digital Health for Effectiveness of Interventions with Evaluative Depth checklist guides DHI evidence quality assessment.

The Economic Implications

The ambiguity in DHI terminology carries substantial economic consequences. Moreover, healthcare providers and payers find it difficult to ascertain the value and efficacy of DHIs, leading to hesitation in financing these technologies. Systematic app evaluation is guided by the Target User, Evaluation Focus, Connectedness, and Health Domain framework. Kolasa et al. extensively assessed 11 DHI value frameworks. As of September 2022, payers have adopted 6 evidence-based frameworks for DHI financing choices. By embracing a standardised framework, we can streamline the evaluation process. Potentially reducing healthcare costs and fostering more widespread adoption of cost-effective DHIs.

The PICOTS-ComTeC Framework

To address these challenges, ISPOR’s research introduces the (population, intervention, comparator, outcome, timing, and setting) PICOTS-ComTeC framework. This tool therefore merges the established PICOTS approach with critical elements of technology and context, enabling precise definitions of DHIs. The framework is designed to aid stakeholders in selecting appropriate interventions and comparators, thereby facilitating better clinical decisions and health economic evaluations.

A Step Towards Standardising DHI Terminology

The adoption of the PICOTS-ComTeC framework represents a significant step towards unifying DHI terminology. By providing detailed, actionable information, it empowers clinicians, researchers, and policymakers to make informed decisions. This clarity is expected to accelerate the integration of DHIs into healthcare systems, ultimately improving patient outcomes and optimising resource allocation.

Conclusion

This research from ISPOR advocates for standardising DHI terminology through the PICOTS-ComTeC framework, which holds the potential to enhance clinical decision-making and health economics. As the digital health landscape evolves, clear and consistent definitions will be crucial in realising the full potential of DHIs, both in terms of patient care and cost-efficiency.

Reference url

Recent Posts

oral health Africa
    

Oral Health in Africa: Promoting Collaborative Solutions

🦷 Is oral health taking a back seat in public health discussions in Africa?

A new article reveals alarming statistics about the high prevalence of untreated dental diseases across the continent and a critical shortage of oral health professionals. It emphasizes the urgent need for collaborative action among healthcare providers and policy-makers to integrate oral health into broader public health frameworks.

Discover how strengthening partnerships can pave the way for improved health outcomes and resource allocation in oral health.

#SyenzaNews #globalhealth #HealthEconomics

tislelizumab NSCLC treatment
        

Early Benefit Assessment of Tislelizumab NSCLC Treatment: Insights and Implications

🧐 How is the evolving treatment landscape for NSCLC affecting patient access to tislelizumab?

The German Federal Joint Committee (G-BA) has launched an early benefit assessment for tislelizumab as a second-line treatment for adults with advanced NSCLC. This assessment notably focuses on PD-L1 negative patients and highlights the need for additional data to substantiate its value amidst a shifting emphasis on first-line immunotherapy.

Explore the nuances of this assessment and its implications for future research and market access in the full article.

#SyenzaNews #oncology #MarketAccess

colorectal cancer screening
    

Advances in Colorectal Cancer Screening: Access and Cost

🚀 Is blood-based screening redefining colorectal cancer detection?

The Shield blood test offers a non-invasive alternative to colonoscopy—boosting screening uptake, but raising questions around effectiveness and value.

🔍 Discover how this innovation could reshape patient care, payer strategy, and health system costs.

#SyenzaNews #HealthcareInnovation #CostEffectiveness #DigitalTransformation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.